Biotech and Pharma Industry News | BioPharma Dive
WEBBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
Pharma News | BioPharma Dive
WEB6 days ago · The latest pharma news for biotech and biopharmaceutical professionals
Radiopharmaceuticals for cancer: Making radiation precise
WEBAug 15, 2023 · Along with surgery, radiation therapy is a mainstay of cancer care, used to treat or prevent the recurrence of tumors in more than half of people with the disease, according to the American Cancer Society.. But radiation therapy is a blunt force.
Novo’s latest obesity pill spurs major weight loss in small trial
WEBMar 7, 2024 · Dive Brief: An experimental pill developed by Novo Nordisk helped obese people lose 13% of their body weight after three months of treatment in a small clinical trial, the company said Thursday, in a result one analyst described as among the best of any weight loss drug tested so far.; The drug, called amycretin, is one of a handful of …
Chasing Novo and Lilly: The obesity drugs that could challenge …
WEBApr 30, 2024 · One study can start a pharmaceutical revolution. Four years ago, a large clinical trial run by Novo Nordisk showed a drug called semaglutide helped people with obesity lose, on average, around 15% of their weight.The results far exceeded what prior studies of other treatments had suggested was possible pharmaceutically, sparking a …
The next era of Greater Boston’s biotech boom | BioPharma Dive
WEBNov 22, 2022 · Groundbreaking science isn’t new to Kendall Square. It’s been a foundation of the Cambridge, Mass. neighborhood since 1876, when Thomas Watson picked up the first-ever “long distance” phone call from his partner, Alexander Graham Bell, at what is now the site of a biotech incubator.
Biotech News - BioPharma Dive
WEB6 days ago · The latest biotech news for biopharmaceutical professionals. Can the Fed’s rate cut change biotech’s ‘new normal’? Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment.
GSK acquires oligonucleotide drug startup Elsie - BioPharma Dive
WEBJun 6, 2024 · Oligonucleotides are small strands of DNA or RNA that can be used to craft drugs that alter gene expression. They’re now a well-established class of medicines that some companies, like GSK, are making more central to their development plans alongside standard proteins and pills.
Full study data back Alnylam heart drug’s benefit, but leave …
WEBAug 30, 2024 · The results are from a study named Helios-B that tested Alnylam’s drug, vutrisiran, against a placebo over several years. In June, Alnylam said trial participants who received vutrisiran had a 28% lower risk of a recurrent cardiovascular event or death from any cause than those given placebo. Treatment was also associated with a 33% risk …
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
WEBFeb 21, 2023 · “If you track the sales of a typical small molecule that goes generic it really goes off the cliff — 80% of the market can be gone in 30 to 90 days and the price goes down even more,” said Richard Kelly, a senior partner with the law firm Oblon, McClelland, Maier & Neustadt who specializes in life sciences intellectual property.